Female flyers risk getting skin and breast cancer

Article

A meta-analysis of the literature indicates that female flight attendants have a higher risk of certain cancers than the general public.

A meta-analysis of the literature indicates that female flight attendants have a higher risk of certain cancers than the general public.

Flight attendants are routinely exposed to cosmic ionizing radiation while traveling at high altitudes. Researchers from the University of Padua in Italy analyzed seven follow-up studies reporting standardized incidence ratio for cancer among female flight attendants obtained from online databases (J Womens Health 2006;15[1]:98-105).

The meta-analysis showed a significant excess of melanoma and breast carcinoma and a slight but not significant excess of cancer incidence across types.

While calling for further studies to clarify the role of occupational exposure, the researchers suggested that airlines estimate radiation dose, organize crew member schedules to reduce further exposure in highly exposed flight attendants, inform crew members about health risks, and give special protection to pregnant women.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.